全文获取类型
收费全文 | 4946篇 |
免费 | 398篇 |
国内免费 | 1篇 |
学科分类
生物科学 | 5345篇 |
出版年
2023年 | 25篇 |
2022年 | 66篇 |
2021年 | 119篇 |
2020年 | 53篇 |
2019年 | 73篇 |
2018年 | 98篇 |
2017年 | 86篇 |
2016年 | 154篇 |
2015年 | 268篇 |
2014年 | 250篇 |
2013年 | 337篇 |
2012年 | 425篇 |
2011年 | 407篇 |
2010年 | 253篇 |
2009年 | 198篇 |
2008年 | 319篇 |
2007年 | 310篇 |
2006年 | 272篇 |
2005年 | 265篇 |
2004年 | 249篇 |
2003年 | 226篇 |
2002年 | 242篇 |
2001年 | 47篇 |
2000年 | 43篇 |
1999年 | 52篇 |
1998年 | 57篇 |
1997年 | 48篇 |
1996年 | 21篇 |
1995年 | 37篇 |
1994年 | 33篇 |
1993年 | 37篇 |
1992年 | 32篇 |
1991年 | 21篇 |
1990年 | 21篇 |
1989年 | 21篇 |
1988年 | 12篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 18篇 |
1984年 | 13篇 |
1983年 | 12篇 |
1982年 | 20篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1976年 | 10篇 |
1973年 | 5篇 |
1972年 | 5篇 |
1969年 | 6篇 |
排序方式: 共有5345条查询结果,搜索用时 0 毫秒
101.
Alexandra M. Nicholson NiCole A. Finch Aleksandra Wojtas Matt C. Baker Ralph B. Perkerson III Monica Castanedes‐Casey Linda Rousseau Luisa Benussi Giuliano Binetti Roberta Ghidoni Ging‐Yuek R. Hsiung Ian R. Mackenzie Elizabeth Finger Bradley F. Boeve Nilüfer Ertekin‐Taner Neill R. Graff‐Radford Dennis W. Dickson Rosa Rademakers 《Journal of neurochemistry》2013,126(6):781-791
Frontotemporal lobar degeneration (FTLD) is the second leading cause of dementia in individuals under age 65. In many patients, the predominant pathology includes neuronal cytoplasmic or intranuclear inclusions of ubiquitinated TAR DNA binding protein 43 (FTLD‐TDP). Recently, a genome‐wide association study identified the first FTLD‐TDP genetic risk factor, in which variants in and around the TMEM106B gene (top SNP rs1990622) were significantly associated with FTLD‐TDP risk. Intriguingly, the most significant association was in FTLD‐TDP patients carrying progranulin (GRN) mutations. Here, we investigated to what extent the coding variant, rs3173615 (p.T185S) in linkage disequilibrium with rs1990622, affects progranulin protein (PGRN) biology and transmembrane protein 106 B (TMEM106B) regulation. First, we confirmed the association of TMEM106B variants with FTLD‐TDP in a new cohort of GRN mutation carriers. We next generated and characterized a TMEM106B‐specific antibody for investigation of this protein. Enzyme‐linked immunoassay analysis of progranulin protein levels showed similar effects upon T185 and S185 TMEM106B over‐expression. However, over‐expression of T185 consistently led to higher TMEM106B protein levels than S185. Cycloheximide treatment experiments revealed that S185 degrades faster than T185 TMEM106B, potentially due to differences in N‐glycosylation at residue N183. Together, our results provide a potential mechanism by which TMEM106B variants lead to differences in FTLD‐TDP risk.
102.
103.
Monica Aasrum John Ødegård Dagny Sandnes Thoralf Christoffersen 《Biochimica et Biophysica Acta (BBA)/Molecular Cell Research》2013,1833(12):3286-3294
Grb2-assosiated binder (Gab) family proteins are docking molecules that can interact with receptor tyrosine kinases (RTKs) and cytokine receptors and bind several downstream signalling proteins. Studies in several cell types have shown that Gab1 may have a role in signalling mediated by the two RTKs epidermal growth factor (EGF) receptor (EGFR) and Met, the receptor for hepatocyte growth factor (HGF), but the involvement of Gab1 in EGFR and Met signalling has not been directly compared in the same cell. We have studied mechanisms of activation and role in mitogenic signalling of Gab1 in response to EGF and HGF in cultured rat hepatocytes. Gab1, but not Gab2, was expressed in the hepatocytes and was phosphorylated upon stimulation with EGF or HGF. Depletion of Gab1, using siRNA, decreased the ERK and Akt activation, cyclin D1 expression, and DNA synthesis in response to both EGF and HGF. Studies of mechanisms of recruitment to the receptors showed that HGF induced co-precipitation of Gab1 and Met while EGF induced binding of Gab1 to Grb2 but not to EGFR. Gab1 activation in response to both EGF and HGF was dependent on PI3K. While EGF activated Gab1 and Shc equally, within the same concentration range, HGF very potently and almost exclusively activated Gab1, having only a minimal effect on Shc. Collectively, our results strongly suggest that although Gab1 interacts differently with EGFR and Met, it is involved in mitogenic signalling mediated by both these growth factor receptors in hepatocytes. 相似文献
104.
Callum F. Ross Richard W. Blob David R. Carrier Monica A. Daley Stephen M. Deban Brigitte Demes Janaya L. Gripper Jose Iriarte‐Diaz Brandon M. Kilbourne Tobias Landberg John D. Polk Nadja Schilling Bieke Vanhooydonck 《Evolution; international journal of organic evolution》2013,67(4):1209-1217
Differences in rhythmicity (relative variance in cycle period) among mammal, fish, and lizard feeding systems have been hypothesized to be associated with differences in their sensorimotor control systems. We tested this hypothesis by examining whether the locomotion of tachymetabolic tetrapods (birds and mammals) is more rhythmic than that of bradymetabolic tetrapods (lizards, alligators, turtles, salamanders). Species averages of intraindividual coefficients of variation in cycle period were compared while controlling for gait and substrate. Variance in locomotor cycle periods is significantly lower in tachymetabolic than in bradymetabolic animals for datasets that include treadmill locomotion, non‐treadmill locomotion, or both. When phylogenetic relationships are taken into account the pooled analyses remain significant, whereas the non‐treadmill and the treadmill analyses become nonsignificant. The co‐occurrence of relatively high rhythmicity in both feeding and locomotor systems of tachymetabolic tetrapods suggests that the anatomical substrate of rhythmicity is in the motor control system, not in the musculoskeletal components. 相似文献
105.
Yonatan B. Tzur Ari E. Friedland Saravanapriah Nadarajan George M. Church John A. Calarco Monica P. Colaiácovo 《Genetics》2013,195(3):1181-1185
We adapted the CRISPR–Cas9 system for template-mediated repair of targeted double-strand breaks via homologous recombination in Caenorhabditis elegans, enabling customized and efficient genome editing. This system can be used to create specific insertions, deletions, and base pair changes in the germline of C. elegans. 相似文献
106.
Simon I. Hay Katherine E. Battle David M. Pigott David L. Smith Catherine L. Moyes Samir Bhatt John S. Brownstein Nigel Collier Monica F. Myers Dylan B. George Peter W. Gething 《Philosophical transactions of the Royal Society of London. Series B, Biological sciences》2013,368(1614)
The primary aim of this review was to evaluate the state of knowledge of the geographical distribution of all infectious diseases of clinical significance to humans. A systematic review was conducted to enumerate cartographic progress, with respect to the data available for mapping and the methods currently applied. The results helped define the minimum information requirements for mapping infectious disease occurrence, and a quantitative framework for assessing the mapping opportunities for all infectious diseases. This revealed that of 355 infectious diseases identified, 174 (49%) have a strong rationale for mapping and of these only 7 (4%) had been comprehensively mapped. A variety of ambitions, such as the quantification of the global burden of infectious disease, international biosurveillance, assessing the likelihood of infectious disease outbreaks and exploring the propensity for infectious disease evolution and emergence, are limited by these omissions. An overview of the factors hindering progress in disease cartography is provided. It is argued that rapid improvement in the landscape of infectious diseases mapping can be made by embracing non-conventional data sources, automation of geo-positioning and mapping procedures enabled by machine learning and information technology, respectively, in addition to harnessing labour of the volunteer ‘cognitive surplus’ through crowdsourcing. 相似文献
107.
108.
109.
Freddy Sitas Alison Gibberd Clare Kahn Marianne F. Weber May Chiew Rajah Supramaniam Louiza Velentzis Carolyn Nickson David P. Smith Dianne O’Connell Megan A. Smith Katie Armstrong Xue Qin Yu Karen Canfell Monica Robotin Eleonora Feletto Andrew Penman 《Cancer epidemiology》2013,37(6):780-787
BackgroundAustralia has one of the highest rates of cancer incidence worldwide and, despite improving survival, cancer continues to be a major public health problem. Our aim was to provide simple summary measures of changes in cancer mortality and incidence in Australia so that progress and areas for improvement in cancer control can be identified.MethodsWe used national data on cancer deaths and newly registered cancer cases and compared expected and observed numbers of deaths and cases diagnosed in 2007. The expected numbers were obtained by applying 1987 age–sex specific rates (average of 1986–1988) directly to the 2007 population. The observed numbers of deaths and incident cases were calculated for 2007 (average of 2006–2008). We limited the analyses to people aged less than 75 years.ResultsThere was a 28% fall in cancer mortality (7827 fewer deaths in 2007 vs. 1987) and a 21% increase in new cancer diagnoses (13,012 more diagnosed cases in 2007). The greatest reductions in deaths were for cancers of the lung in males (?2259), bowel (?1797), breast (?773) and stomach (?577). Other notable falls were for cancers of the prostate (?295), cervix (?242) and non-Hodgkin lymphoma (?240). Only small or no changes occurred in mortality for cancers of the lung (female only), pancreas, brain and related, oesophagus and thyroid, with an increase in liver cancer (267). Cancer types that showed the greatest increase in incident cases were cancers of the prostate (10,245), breast (2736), other cancers (1353), melanoma (1138) and thyroid (1107), while falls were seen for cancers of the lung (?1705), bladder (?1110) and unknown primary (?904).ConclusionsThe reduction in mortality indicates that prevention strategies, improvements in cancer treatment, and screening programmes have made significant contributions to cancer control in Australia since 1987. The rise in incidence is partly due to diagnoses being brought forward by technological improvements and increased coverage of screening and early diagnostic testing. 相似文献
110.
Monica Rolando Serena Sanulli Christophe Rusniok Laura Gomez-Valero Clement Bertholet Tobias Sahr Raphael Margueron Carmen Buchrieser 《Cell host & microbe》2013,13(4):395-405
Highlights? Upon infection, L. pneumophila secretes RomA, a SET domain-containing methyltransferase ? RomA triggers H3K14 trimethylation, causing a switch from gene activation to repression ? ChIP-seq identified 4,870 H3K14 methylated promoter regions, including innate immune genes ? RomA SET domain is required for efficient intracellular replication of L. pneumophila 相似文献